bombesin
| SMILES | CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C |
| InChIKey | QXZBMSIDSOZZHK-DOPDSADYSA-N |
| Sequence | XQRLGNQWAVGHLM |
Chemical properties
| Hydrogen bond acceptors | 21 |
| Hydrogen bond donors | 23 |
| Rotatable bonds | 51 |
| Molecular weight (Da) | 1618.8 |
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| BB1 | NMBR | Human | Bombesin | A | pKi | 7.47 | 7.48 | 7.49 | Guide to Pharmacology |
| BB2 | GRPR | Human | Bombesin | A | pKi | 7.36 | 8.11 | 8.85 | Guide to Pharmacology |
| BB2 | GRPR | Rat | Bombesin | A | pKi | 8.39 | 8.39 | 8.39 | Guide to Pharmacology |
| BB1 | NMBR | Rat | Bombesin | A | pKi | 7.47 | 7.57 | 7.68 | Guide to Pharmacology |
| BB2 | GRPR | Human | Bombesin | A | pKi | 9.82 | 9.82 | 9.82 | ChEMBL |
| BB1 | NMBR | Human | Bombesin | A | pKi | 8.7 | 8.7 | 8.7 | ChEMBL |
| BB2 | GRPR | Mouse | Bombesin | A | pKi | 8.17 | 8.61 | 9.05 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| BB1 | NMBR | Human | Bombesin | A | pIC50 | 8.43 | 8.59 | 8.75 | Guide to Pharmacology |
| BB2 | GRPR | Human | Bombesin | A | pIC50 | 9.77 | 9.96 | 10.15 | Guide to Pharmacology |
| BB2 | GRPR | Human | Bombesin | A | pEC50 | 9.59 | 9.59 | 9.59 | ChEMBL |
| BB2 | GRPR | Human | Bombesin | A | pIC50 | 8.7 | 8.7 | 8.7 | ChEMBL |
| Y1 | NPY1R | Human | Neuropeptide Y | A | pIC50 | 8.33 | 8.33 | 8.33 | ChEMBL |